1. Home
  2. BNTC vs KLXE Comparison

BNTC vs KLXE Comparison

Compare BNTC & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • KLXE
  • Stock Information
  • Founded
  • BNTC 1995
  • KLXE 2018
  • Country
  • BNTC United States
  • KLXE United States
  • Employees
  • BNTC N/A
  • KLXE N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • KLXE Oilfield Services/Equipment
  • Sector
  • BNTC Health Care
  • KLXE Energy
  • Exchange
  • BNTC Nasdaq
  • KLXE Nasdaq
  • Market Cap
  • BNTC 88.1M
  • KLXE 97.2M
  • IPO Year
  • BNTC N/A
  • KLXE N/A
  • Fundamental
  • Price
  • BNTC $9.02
  • KLXE $6.22
  • Analyst Decision
  • BNTC Buy
  • KLXE Hold
  • Analyst Count
  • BNTC 3
  • KLXE 1
  • Target Price
  • BNTC $19.67
  • KLXE $4.50
  • AVG Volume (30 Days)
  • BNTC 14.6K
  • KLXE 154.7K
  • Earning Date
  • BNTC 09-19-2024
  • KLXE 11-04-2024
  • Dividend Yield
  • BNTC N/A
  • KLXE N/A
  • EPS Growth
  • BNTC N/A
  • KLXE N/A
  • EPS
  • BNTC N/A
  • KLXE N/A
  • Revenue
  • BNTC $7,000.00
  • KLXE $769,700,000.00
  • Revenue This Year
  • BNTC N/A
  • KLXE N/A
  • Revenue Next Year
  • BNTC N/A
  • KLXE $3.52
  • P/E Ratio
  • BNTC N/A
  • KLXE N/A
  • Revenue Growth
  • BNTC N/A
  • KLXE N/A
  • 52 Week Low
  • BNTC $2.69
  • KLXE $4.18
  • 52 Week High
  • BNTC $10.88
  • KLXE $12.56
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 51.72
  • KLXE 43.31
  • Support Level
  • BNTC $8.60
  • KLXE $6.86
  • Resistance Level
  • BNTC $9.06
  • KLXE $7.66
  • Average True Range (ATR)
  • BNTC 0.40
  • KLXE 0.45
  • MACD
  • BNTC -0.02
  • KLXE -0.15
  • Stochastic Oscillator
  • BNTC 56.96
  • KLXE 1.71

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks: